Skip to main content
Equibles

CITADEL ADVISORS LLC

Position in TGTX — Tg Therapeutics, Inc.

CIK 1423053 MIAMI, FL
Back to TGTX Full portfolio

Position in TGTX

as of Jun 30, 2026 · filed Sep 2, 2026
Position Value
$29,512,119
-$34,366,252 QoQ
Shares Held
537,170
-72.1% QoQ
Ownership
0.351%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#33
of 426 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in TGTX Over Time

Shares Held

Position Value (USD)

Derivatives in TGTX

reported options exposure · as of Jun 30, 2026
CallValue
$20,970,598
CallShares
381,700
PutValue
$17,679,692
PutShares
321,800

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

CITADEL ADVISORS LLC holds $6,150,763,744 across 435 Biotechnology names. TGTX ranks #42 (0.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ONC
BeOne Medicines Ltd.
 1,425,517 $406,229,578
2 BBIO
BridgeBio Pharma, Inc.
 3,760,028 $280,046,885
3 INSM
INSMED Inc
 2,556,973 $272,624,460
4 MDGL
Madrigal Pharmaceuticals, Inc.
 507,233 $272,358,759
5 VRTX
Vertex Pharmaceuticals Inc / Ma
 510,430 $253,545,893
6 JAZZ
Jazz Pharmaceuticals plc
 1,006,676 $242,578,715
7 MANE
Veradermics, Inc
 1,877,775 $230,853,658
8 ROIV
Roivant Sciences Ltd.
 5,576,261 $197,343,876

All Filings in TGTX

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $29,512,119 537,170
2026-06-30 $17,679,692 321,800
2026-06-30 $20,970,598 381,700
2026-03-31 $10,201,862 307,100
2026-03-31 $7,105,758 213,900
2026-03-31 $63,878,371 1,922,889
2025-12-31 $6,671,478 223,800
2025-12-31 $30,139,012 1,011,037
2025-12-31 $11,500,698 385,800
2025-09-30 $35,861,395 992,703
2025-09-30 $13,178,400 364,800
2025-09-30 $11,769,525 325,800
2025-06-30 $17,854,639 496,100
2025-06-30 $37,590,403 1,044,468
2025-06-30 $14,338,416 398,400
2025-03-31 $15,842,974 401,800
2025-03-31 $25,466,929 645,877
2025-03-31 $21,907,308 555,600
2024-12-31 $9,779,490 324,900
2024-12-31 $16,410,520 545,200
2024-12-31 $15,470,196 513,960
2024-09-30 $7,641,513 326,700
2024-09-30 $6,263,842 267,800
2024-09-30 $2,926,884 125,134
2024-06-30 $33,085,699 1,859,792
2024-06-30 $3,301,824 185,600
2024-06-30 $4,431,489 249,100
2024-03-31 $5,315,895 349,500
2024-03-31 $3,356,847 220,700
2024-03-31 $28,569,444 1,878,333
2023-12-31 $7,933,010 464,462
2023-12-31 $11,231,808 657,600
2023-12-31 $6,174,420 361,500
2023-09-30 $3,988,556 477,100
2023-09-30 $2,433,596 291,100
2023-09-30 $3,212,839 384,311
2023-06-30 $4,455,525 179,369
2023-06-30 $16,794,324 676,100
2023-06-30 $9,789,444 394,100
2023-03-31 $5,054,944 336,100
2023-03-31 $16,066,404 1,068,245
2023-03-31 $6,783,040 451,000
2022-12-31 $11,197,095 946,500
2022-12-31 $7,327,502 619,400
2022-12-31 $4,153,512 351,100
2022-09-30 $5,275,904 891,200
2022-09-30 $9,255,179 1,563,375
2022-09-30 $1,740,480 294,000
2022-06-30 $3,174,325 746,900
2022-06-30 $1,564,425 368,100